Slide

ABOUT VECTANS PHARMA

Vectans Pharma is an international pharmaceutical company bringing a new therapeutic approach with its Lauriad® technology born of French R&D.

This innovative technology enables targeted and prolonged diffusion of APIs, thus optimizing effectiveness and compliance for the benefit of patients.

Vectans Pharma's portfolio currently comprises two products, Sitavig® and Loramyc®, both market-approved by American (FDA), European (EMA) and Japanese (PMDA) health authorities

 

Through international licensing agreements, Loramyc®; is commercialized in the United States, Japan, Italy and France, and Sitavig®; in the United States and France.

NEWS

posts-VECTANS2022-pierre ATTALI

Vectans Pharma participated in a symposium about new treatments in Oropharyngeal Candidiasis

Dr Pierre Attali, our Chief Medical Officer, represented Vectans Pharma at the symposium organized by our Japanese partner Sosei Heptares about new treatments.
230 Bureaux de la colline
92213 Saint-Cloud
France

contact@vectans.com

logo-vectans-bleu-04

Copyright © VECTANS PHARMA